Fluorometholone Neomycin Sulphate

1. Dual-Action Therapeutic Effect

• Fluorometholone (0.1%):

Medium-potency corticosteroid for ocular inflammation control
Lower risk of intraocular pressure elevation vs. other steroids

• Neomycin Sulphate (0.35%):

Broad-spectrum coverage against Staphylococcus, E. coli, Proteus
Effective against 90% of common ocular pathogens
 

2. Specialized Ophthalmic Benefits
✔ Enhanced corneal penetration
✔ Reduced stinging sensation (optimized pH balance)
✔ Preservative-balanced formula (safe for short-term use)
 

3. Clinical Applications
Post-operative ocular inflammation (cataract/refractive surgery)
Allergic conjunctivitis with infection risk
Blepharoconjunctivitis treatment
Corneal inflammatory conditions
Veterinary ophthalmic use (canine conjunctivitis)

1. Superior Safety Profile
Lower steroid potency minimizes glaucoma risk
Bacteriostatic + anti-inflammatory action prevents secondary infections
 

2. Technical Innovations
Suspension technology ensures dose uniformity
Patented delivery system enhances drug availability
 

3. Market Differentiation
Only 1:3 steroid-antibiotic ratio proven optimal in clinical trials
No generic equivalents with this exact formulation
 

4. Quality Assurance
Aseptic filling process (ISO Class 8 cleanroom)
Each batch tested for:
Sterility (USP <71>)
Particle size distribution
Osmolality (280-320 mOsm/kg)

Ophthalmology Clinics: Post-surgical care standard
Hospital ER: Trauma-induced ocular inflammation
Veterinary Practices: Companion animal eye infections
Travel Kits: For contact lens-related inflammations

For formulation details & clinical studies:
Email: marketing@highchem-pharm.cn